FDA Approved: * January 26, 2016 Pharm Company: *ACTAVIS ELIZABETH Category:Iron Chelator
Deferasirox, sold under the brand name Exjade & Asunra (in injectable form) & Oleptiss (Tablet formulation) both by Novartis among others, is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias. It is the first oral medication approved in the United States for this purpose.
It was appro...
* May have multiple approval dates, manufacturers, or labelers.